Evidence map›Paper›PMID 27924492›Full record

ArticleCerebellum (London, England)2017

Progression of Gait Ataxia in Patients with Degenerative Cerebellar Disorders: a 4-Year Follow-Up Study.

Mariano Serrao, Giorgia Chini, Carlo Casali, Carmela Conte, Martina Rinaldi, Alberto Ranavolo, Christian Marcotulli, Luca Leonardi, Gaia Fragiotta, Fabiano Bini and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Cerebellum (London, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Consensus Paper: Ataxic Gait.Cerebellum (London, England) · 2023
    Article
  11. Article
  12. Neurophysiology of cerebellar ataxias and gait disorders.Clinical neurophysiology practice · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Mariano SerraoDepartment of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, Via Faggiana 1668, 40100, Latina, Italy. mariano.serrao@uniroma1.it.
Giorgia ChiniRehabilitation Centre Policlinico Italia, Piazza del Campidano 6, 00162, Rome, Italy.
Carlo CasaliDepartment of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, Via Faggiana 1668, 40100, Latina, Italy.
Carmela ConteFondazione Don Gnocchi Foundation, Milan, Italy.
Martina RinaldiRehabilitation Centre Policlinico Italia, Piazza del Campidano 6, 00162, Rome, Italy.
Alberto RanavoloDepartment of Occupational and Environmental Medicine, Epidemiology and Hygiene, INAIL, Via Fontana Candida 1, 00040, Monte Porzio Catone, Italy.
Christian MarcotulliDepartment of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, Via Faggiana 1668, 40100, Latina, Italy.
Luca LeonardiDepartment of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, Via Faggiana 1668, 40100, Latina, Italy.
Gaia FragiottaDepartment of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, Via Faggiana 1668, 40100, Latina, Italy.
Fabiano BiniDepartment of Mechanical and Aerospace Engineering, "Sapienza" University of Rome, Via Eudossiana 18, 00184, Rome, Italy.
Gianluca CoppolaDepartment of Neurophysiology of Vision and Neurophthalmology, G.B. Bietti Foundation-IRCCS, Via Livenza 3, 00198, Rome, Italy.
Francesco PierelliDepartment of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, Via Faggiana 1668, 40100, Latina, Italy.
Sapienza University of Rome · ITRoma Tre University · ITDon Carlo Gnocchi Foundation · ITFondazione G.B. Bietti · ITIstituto Nazionale per l'Assicurazione Contro gli Infortuni sul Lavoro · ITIstituto Neurologico Mediterraneo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the present study, the progression of gait impairment in a group of patients with primary degenerative cerebellar ataxias was observed over a period of 4 years. A total of 30 patients underwent an initial gait analysis study, and thereafter only 12 were evaluated because they completed the 2- and 4-year follow-up evaluations. Time-distance parameters, trunk and joint range of motion (RoM), and variability parameters (e.g., coefficients of variation) were measured at the baseline and at each follow-up evaluation. The scale for the assessment and rating of ataxia (SARA) was used to evaluate disease severity. We found a significant increase in the SARA score at both the 2- and 4-year follow-up evaluations. Almost all the gait variables changed significantly only at the 4-year follow-up. Particularly, we found a significant decrease in the step length and in the hip, knee, and ankle joint RoM values and noted a significant increase in the trunk rotation RoM and stride-to-stride and step length variability. Furthermore, a significant difference in ankle joint RoM was found between spinocerebellar ataxia and sporadic adult-onset ataxia patients, with the value being lower in the former group of patients. Our findings suggest that patients with degenerative cerebellar ataxias exhibit gait decline after 4 years from the baseline. Moreover, patients try to maintain an effective gait by adopting different compensatory mechanisms during the course of the disease in spite of disease progression.

Indexed as

AdultAgedCerebellar AtaxiaCerebellar DiseasesDisease ProgressionFemaleFollow-Up StudiesGaitGait AtaxiaHumansMaleMiddle AgedSeverity of Illness IndexCerebellar ataxiaGaitLongitudinalPhenotype

Identifiers

PMID27924492
OpenAlexW2559774873

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.